Antiapoptotic actions of monoamine oxidase B inhibitors.
Paterson
I A
IA
Neuropsychiatry Research Unit, University of Saskatchewan, Saskatoon, Canada.
Tatton
W G
WG
D000818:Animals; D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology; D002478:Cells, Cultured; D002531:Cerebellum / Q000166:cytology; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D016716:PC12 Cells; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012642:Selegiline / Q000494:pharmacology*
D007527:Isoenzymes; D008996:Monoamine Oxidase Inhibitors; D011437:Propylamines; C094098:N-2-hexyl-N-methylpropargylamine; D012642:Selegiline